Clinical Potential of Nicorandil to Inhibit Major Cardiac Events in Hemodialysis Patients with Suspected Myocardial Ischemia

Publisher： Karger

E-ISSN： 1660-2110|111|3|c212-c221

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.111, Iss.3, 2009-02, pp. : c212-c221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Potential of Oral Nicorandil to Improve Myocardial Fatty Acid Metabolism after Percutaneous Coronary Intervention in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-01 ,pp. : 24-32

Karger

Access to resources Recommend Favorite

Three‐year clinical outcome after infrapopliteal angioplasty for critical limb ischemia in hemodialysis patients with minor or major tissue loss

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 289-298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral Nicorandil for Prevention of Cardiac Death in Hemodialysis Patients without Obstructive Coronary Artery Disease: A Propensity-Matched Patient Analysis

By  

Nephron Clin Pract, Vol. 119, Iss. 4, 2011-09 ,pp. : c301-c309

Karger

Access to resources Recommend Favorite

Short- and Long-Term Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention with Stenting for Acute Myocardial Infarction Complicated by Cardiogenic Shock

By  

Cardiology, Vol. 121, Iss. 1, 2012-03 ,pp. : 47-55

Karger

Access to resources Recommend Favorite

Value of Resting Echocardiographic Findings and Dobutamine Stress Echocardiography for Diagnosing Myocardial Ischemia in Patients with Suspected Angina Pectoris

By  

ECHOCARDIOGRAPHY (ELECTRONIC), Vol. 32, Iss. 6, 2015-06 ,pp. : 993-1002

John Wiley & Sons Inc

Access to resources Recommend Favorite